What an NDA Actually Protects — Trade Secrets vs. Confidential Information: DTSA § 1839(3), UTSA, and What Courts Actually Enforce
Example Contract Language
"'Confidential Information' means any and all information disclosed by the Disclosing Party to the Receiving Party, whether orally, in writing, electronically, or by any other means, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure, including without limitation trade secrets, business plans, financial information, technical data, customer lists, supplier lists, pricing information, product designs, software, algorithms, research, and any other proprietary information of any kind."
Non-disclosure agreements protect three analytically distinct categories of information, but most NDAs treat them identically — which creates enforcement gaps, overreach, and strategic miscalculations for both sides. Understanding the legal distinctions determines what is protected, what remedies are available, and what the receiving party must actually do to stay compliant.
Trade Secrets: The Statutory Definition. Under the Defend Trade Secrets Act (DTSA), 18 U.S.C. § 1839(3), a "trade secret" means "all forms and types of financial, business, scientific, technical, economic, or engineering information, including patterns, plans, compilations, program devices, formulas, designs, prototypes, methods, techniques, processes, procedures, programs, or codes, whether tangible or intangible, and whether or how stored, compiled, or memorialized physically, electronically, graphically, photographically, or in writing if — (A) the owner thereof has taken reasonable measures to keep such information secret; and (B) the information derives independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable through proper means by, another person who can obtain economic value from the disclosure or use of the information." The Uniform Trade Secrets Act (UTSA), adopted in substantially similar form in 48 states (all except New York and North Carolina, which have their own statutes), uses nearly identical language. Trade secrets can be protected indefinitely — the Coca-Cola formula has been a trade secret since 1886, the recipe maintained in a vault in Atlanta.
The "Reasonable Measures" Requirement. This is where most trade secret cases are won or lost. In Waymo LLC v. Uber Technologies, Inc. (N.D. Cal. 2018), Waymo alleged that Anthony Levandowski downloaded approximately 14,000 confidential files before departing to found Otto, which Uber subsequently acquired. Uber's partial defense — that Waymo had not taken adequate reasonable measures — was overcome by evidence of Waymo's access controls, NDA practices, and data security protocols. The case settled for approximately $245 million in Uber equity before trial. The lesson: a company cannot claim trade secret protection for information it does not actively protect. Reasonable measures include: restricted computer access, physical security, employee NDAs, vendor NDAs, marking of sensitive documents, and access logs. Courts evaluate the totality of these measures — no single measure is sufficient, and the adequacy is judged in proportion to the information's value.
Confidential Information: Broader than Trade Secrets. "Confidential information" in an NDA is a contractual category, not a legal one. It encompasses any non-public business information the disclosing party designates as protected — financial projections, strategic plans, personnel data, unreleased product roadmaps, customer acquisition costs, and competitive analysis — regardless of whether each item independently qualifies as a trade secret. The critical distinction is durational: contractual confidentiality protection expires when the NDA's term ends. A business plan shared under a 3-year NDA loses contractual protection after year 3, even if the underlying information is still sensitive. Trade secrets do not expire with the NDA's term — they remain protected under the DTSA and applicable state UTSA until they no longer qualify (i.e., they become publicly known or the owner ceases maintaining reasonable measures).
The "Reasonably Should Understand" Standard and Its Limits. The clause above uses the objective "reasonably should be understood to be confidential" standard — which courts have generally applied, but with important limitations. In Buffets, Inc. v. Klinke (W.D. Wash. 1995), the court refused to enforce a blanket confidentiality obligation covering "all information" because such a definition was so overbroad it could prevent the receiving party from using general industry knowledge. The Ninth Circuit has repeatedly noted that overbroad definitions that would encompass publicly available or general knowledge information can void or narrow the confidentiality obligation entirely. Some courts also apply a "specificity rule" — the disclosing party must identify the specific information claimed as confidential with sufficient particularity to put the receiving party on notice of what is restricted.
Derivative Works and Negative Information. Two categories frequently overlooked: (1) *Derivative works* — if the receiving party analyzes the disclosing party's confidential information and creates its own analysis, reports, or conclusions, are those derivative works themselves confidential? Many NDAs say yes; courts are split. Negotiate expressly to exclude or include derivative works. (2) *Negative information* — the knowledge that a compound does NOT work, or that a market is NOT viable, can itself be commercially valuable. In pharmaceutical and biotech NDAs, specifically negotiate whether negative results and null findings are included in the definition. If they are not excluded, a competitor could be prevented from disclosing information that your research found to be valueless — which is commercially absurd.
Proprietary Information: Marketing, Not Law. The term "Proprietary Information," when used in NDAs, is a marketing designation, not a legal term of art. Courts treat it identically to "Confidential Information" unless the NDA explicitly defines a distinction. If your NDA defines both "Confidential Information" and "Proprietary Information" as separate defined terms with different protections, review them carefully for any substantive difference — most of the time, one is redundant and can be consolidated for clarity.
What to Do
As the receiving party: narrow the definition by listing specific categories (financial data, customer lists, technical specifications, product roadmaps, personnel data) rather than using a catch-all; require that oral disclosures be confirmed in writing within 30 days; confirm that all four standard exclusions are present (Section 04). As the disclosing party: document your reasonable measures — access logs, NDA registers, marking policies — and mark truly sensitive documents "Confidential" or "Trade Secret — Protect Accordingly" at the time of disclosure. An overbroad NDA with sloppy implementation is legally weaker than a narrower NDA with rigorous internal discipline.